Globus Medical, Inc. Share Price
Equities
GMED
US3795772082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.57 USD | -0.74% |
|
-15.30% | -13.45% |
| Capitalization | 10.26B 8.76B 8.03B 7.59B 14.05B 982B 14.12B 95.58B 37.21B 466B 38.49B 37.68B 1,619B | P/E ratio 2026 * |
19.4x | P/E ratio 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 10.26B 8.76B 8.03B 7.59B 14.05B 982B 14.12B 95.58B 37.21B 466B 38.49B 37.68B 1,619B | EV / Sales 2026 * |
3.2x | EV / Sales 2027 * | 3.01x |
| Free-Float |
82.89% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Globus Medical, Inc.
| 1 day | -0.74% | ||
| 1 week | -15.30% | ||
| Current month | -16.20% | ||
| 1 month | -18.72% | ||
| 3 months | -14.21% | ||
| 6 months | -10.03% | ||
| Current year | -13.45% |
| 1 week | 74.5 |  | 85.55 |
| 1 month | 74.5 | | 97.39 |
| Current year | 74.5 | | 101.4 |
| 1 year | 51.79 | | 101.4 |
| 3 years | 43.38 | | 101.4 |
| 5 years | 43.38 | | 101.4 |
| 10 years | 19.25 | | 101.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 47 | 17/07/2025 |
Kyle Kline
DFI | Director of Finance/CFO | 41 | 17/07/2025 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 59 | 31/12/2002 |
David Davidar
BRD | Director/Board Member | 60 | 31/12/2002 |
Daniel Lemaitre
BRD | Director/Board Member | 72 | 20/04/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 1.01% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.74% | -15.30% | +29.73% | +32.98% | 10.26B | |
| -0.62% | -2.86% | -35.04% | -24.13% | 146B | |
| -0.79% | -1.79% | -10.46% | -14.26% | 97.84B | |
| -0.04% | +0.58% | +54.24% | +79.68% | 58.66B | |
| -2.01% | +1.16% | -8.36% | +49.53% | 49.75B | |
| -2.26% | -0.40% | -17.77% | -42.90% | 39.73B | |
| +0.42% | -7.86% | - | - | 32.73B | |
| -4.20% | -2.97% | -30.36% | -51.87% | 22.6B | |
| -3.10% | -3.25% | +40.08% | -16.00% | 21.36B | |
| +0.12% | -1.57% | -8.67% | +0.12% | 20.7B | |
| Average | -1.32% | -3.09% | +1.49% | +1.46% | 49.96B | |
| Weighted average by Cap. | -1.03% | -2.14% | -8.11% | -1.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2B 2.74B 2.51B 2.37B 4.39B 307B 4.41B 29.84B 11.62B 145B 12.02B 11.77B 506B | 3.41B 2.91B 2.67B 2.52B 4.67B 326B 4.69B 31.74B 12.36B 155B 12.78B 12.52B 538B |
| Net income | 540M 461M 422M 399M 740M 51.67B 743M 5.03B 1.96B 24.52B 2.03B 1.98B 85.23B | 600M 512M 469M 444M 821M 57.39B 826M 5.59B 2.18B 27.23B 2.25B 2.2B 94.66B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/26 | 75.57 $ | -0.74% | 1,680,892 |
| 12/05/26 | 76.13 $ | -0.72% | 2,415,059 |
| 11/05/26 | 76.68 $ | -1.63% | 2,697,029 |
| 08/05/26 | 77.95 $ | -8.37% | 6,038,701 |
| 07/05/26 | 85.07 $ | -4.65% | 2,931,862 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition